Kallikrein-5 As a Novel Serum Biomarker in Hepatocellular Carcinoma

被引：0
|
作者：
Pestana, Roberto Carmagnani [1 ]
Hassan, Manal M. [2 ]
Ali, Reham Abdelwahab Hassan [3 ]
Mohamed, Yehia I. [4 ]
Kaseb, Ahmed Omar [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
891
引用
收藏
页码：523A / 523A
页数：1
相关论文
共 50 条
  • [31] NOVEL BIOMARKER FOR HEPATOCELLULAR CARCINOMA: THE ANTIOXIDANT RESPONSE IN THE CARCINOGENESIS
    Sanchez-Rodriguez, R.
    Torres-Mena, J. E.
    Quintanar-Jurado, V.
    Villa-Trevino, S.
    Chagoya-Hazas, V.
    Rojas del Castillo, E.
    Velasco-Loyden, G.
    Pozo-Yauner, L.
    Carrillo-Sanchez, K.
    Perez-Carreon, J. I.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S209 - S209
  • [32] SERUM ANGIOPOIETIN 2 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN HEPATOCELLULAR CARCINOMA
    Chiba, Tetsuhiro
    Ao, Junjie
    Kanzaki, Hiroaki
    Ma, Yaojia
    Iwanaga, Terunao
    Sakuma, Takahumi
    Kan, Motoyasu
    Fujita, Naoto
    Koroki, Keisuke
    Kanayama, Ken Go
    Kobayashi, Kazuhumi
    Nakamura, Masato
    Kanogawa, Naoya
    Kiyono, Soichiro
    Kondo, Takayuki
    Saito, Tomoko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Nakagawa, Ryo
    Muroyama, Ryosuke
    Kato, Naoya
    HEPATOLOGY, 2020, 72 : 685A - 686A
  • [33] AGALACTOSYLATION OF SERUM IMMUNOGLOBULIN G AS A POTENTIAL BIOMARKER FOR HEPATOCELLULAR CARCINOMA
    Matsushita, Hiroshi
    Nouso, Kazuhiro
    Dohi, Chihiro
    Miyahara, Koji
    Kinugasa, Hideaki
    Terasawa, Hiroyuki
    Hirai, Mami
    Nishimura, Shin-Ichiro
    Okada, Hiroyuki
    GASTROENTEROLOGY, 2019, 156 (06) : S1310 - S1310
  • [34] Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
    Kim, Seung Up
    Park, Jeon Han
    Kim, Hyon-Suk
    Lee, Jae Myun
    Lee, Hyun Gyu
    Kim, Hyemi
    Choi, Sung Hoon
    Baek, Shinhwa
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Jong Doo
    Han, Kwang-Hyub
    YONSEI MEDICAL JOURNAL, 2015, 56 (05) : 1296 - 1306
  • [35] Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma
    Jeng, Jen-Eing
    Chuang, Lea-Yea
    Chuang, Wan-Lung
    Tsai, Jung-Fa
    CHINESE CLINICAL ONCOLOGY, 2012, 1 (01)
  • [36] Comparative analysis of the serum proteomes for discovery of biomarker of hepatocellular carcinoma
    Lee, E.
    Kim, H.
    Paik, Y.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S155 - S155
  • [37] Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma
    Abuduhadeer, Xiaokaiti
    Xu, Xincai
    Aihesan, Kamali
    Yilihamu, Maimaiti
    Zhao, Yanjun
    Zhang, Wenbin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (10)
  • [38] Kallikrein-5 Promotes Cleavage of Desmoglein-1 and Loss of Cell-Cell Cohesion in Oral Squamous Cell Carcinoma
    Jiang, Rong
    Shi, Zonggao
    Johnson, Jeffrey J.
    Liu, Yueying
    Stack, M. Sharon
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (11) : 9127 - 9135
  • [39] Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
    Zheng, Zhi-kun
    Pang, Cui
    Yang, Yang
    Duan, Qiong
    Zhang, Ju
    Liu, Wen-chao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (01) : 348 - 356
  • [40] Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses
    Di Paolo, Caitlin T.
    Filippou, Panagiota S.
    Yu, Yijing
    Poda, Gennadiy
    Diamandis, Eleftherios P.
    Prassas, Ioannis
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (11) : 1737 - 1743
12345